慢性乙肝增加急性戊型肝炎患者肝相关死亡率:2000至2016年全港队列研究
该研究基于香港医院管理局2000至2016年电子病历,纳入1068例急性甲型肝炎和846例急性戊型肝炎患者,评估诊断后30天内的肝脏事件与死亡。急性戊型肝炎患者30天全因死亡、肝相关死亡及肝脏事件均高于急性甲型肝炎;合并慢性乙肝是急性戊型肝炎30天肝相关死亡的独立危险因素。
要点
- 急性戊型肝炎30天全因死亡率3.9%,高于急性甲型肝炎的0.6%。
- 急性戊型肝炎合并慢性乙肝者30天肝相关死亡风险升高(aHR 3.34)。
- 年龄≥50岁和肾功能衰竭与急性戊型肝炎30天全因死亡相关。
核心结论
- 急性戊型肝炎患者死亡率高于急性甲型肝炎患者。
- 合并慢性乙肝是急性戊型肝炎患者30天肝相关死亡的独立危险因素。
研究设计与样本
- 队列包括1068例急性甲型肝炎和846例急性戊型肝炎,评估诊断后30天内的肝脏事件、全因死亡和肝相关死亡。
主要发现
- 急性戊型肝炎患者合并慢性乙肝比例高于急性甲型肝炎(13.5% vs 8.0%;P < .001)。
- 急性戊型肝炎30天全因死亡3.9% vs 0.6%(P < .001),肝相关死亡2.0% vs 0.3%(P < .001),肝脏事件2.8% vs 0.3%(P < .001)。
- 急性戊型肝炎中,肾功能衰竭(aHR 3.90;P < .001)和年龄≥50岁(aHR 3.25;P = .036)与30天全因死亡相关。
- 急性戊型肝炎中,慢性乙肝(aHR 3.34;P = .02)与30天肝相关死亡相关。
临床怎么用
- 对急性戊型肝炎患者应评估是否合并慢性乙肝,以识别30天肝相关死亡高风险人群。
- 对急性戊型肝炎合并肾功能衰竭或年龄≥50岁者,应关注30天全因死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The epidemiology of acute hepatitis A and E has been changing over the last 2 decades. The impact of concomitant chronic hepatitis B (CHB) on clinical outcomes remains unclear. We aimed to evaluate the morbidity and mortality of patients with acute hepatitis A or E with and without underlying CHB. METHODS: We identified consecutive patients with acute hepatitis A or E based on hepatitis serology from the electronic medical records of the Hospital Authority of Hong Kong from January 2000 to December 2016. Hepatic events, all-cause mortality, and liver-related mortality within 30 days of the diagnosis of acute hepatitis were evaluated. RESULTS: The cohort included 1068 cases of acute hepatitis A and 846 cases of acute hepatitis E. More patients with acute hepatitis E than those with acute hepatitis A had underlying CHB (13.5% vs 8.0%; P < .001). Patients with hepatitis E had more all-cause mortality (3.9% vs 0.6%; P < .001), liver-related mortality (2.0% vs 0.3%; P < .001), and hepatic events (2.8% vs 0.3%; P < .001) within 30 days from diagnosis. In patients with acute hepatitis E, underlying renal failure (adjusted hazard ratio [aHR], 3.90; P < .001) and age ≥50 years (aHR, 3.25; P = .036) were associated with 30-day all-cause mortality, whereas CHB (aHR, 3.34; P = .02) was associated with 30-day liver-related mortality. CONCLUSIONS: The mortality is higher in patients with acute hepatitis E than in those with hepatitis A. Coexisting CHB is the independent risk factor for liver-related mortality in patients with acute hepatitis E.
引用
- Lai JC, Wong GL, Yip TC, et al. Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016. Clin Infect Dis. 2018. PMID: 30265321. doi:10.1093/cid/ciy234
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。